secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dare Bioscience, Inc. (DARE)
CIK:        0001401914
Form:       8-K
Filed at:   2023-03-31T23:59:59+00:00
Accession:  0001493152-23-010311
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Daré Bioscience enters into ATM equity offering program with Stifel and Cantor
------------------------------------------------------------------------------

- Entered into sales agreement with Stifel and Cantor for at-the-market equity offering of common stock.
- Commission of 3.0% of gross proceeds payable to sales agents.
- Shares sold under existing shelf registration statement filed March 30, 2021.
- Company sets parameters including maximum shares, time period, and minimum price.
- Sales may be made on Nasdaq or in privately negotiated transactions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401914/000149315223010311/0001493152-23-010311-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401914/000149315223010311/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-010311

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer